Skip to main content
TipRanks
Go Ultimate75% OFF

Neumora Therapeutics, Inc. (NMRA) Stock Forecast & Price Target

454 Followers
See the Price Targets and Ratings of:

NMRA Analyst Ratings

Moderate Buy
2Ratings
2Buy0Hold0Sell
Based on 2 analysts giving stock ratings to Neumora Therapeutics, Inc. in the past 3 months

NMRA Stock 12 Month Forecast

$5.00▲(1068.22% Upside)
Based on 2 Wall Street analysts offering 12 month price targets for Neumora Therapeutics, Inc. in the last 3 months. The average price target is $5.00 with a high forecast of $7.00 and a low forecast of $3.00. The average price target represents a 1068.22% change from the last price of $0.43.
Highest Price Target$7.00Average Price Target$5.00Lowest Price Target$3.00

Detailed List of Analyst Forecasts​

Analyst Type
Ranks
Analyst Rating
Upside/ Downside
Action
Analyst forecasts for NMRA
Price TargetArticle
Mizuho Securities$4→$3buy600.93%UpsideReiterated10/29/26
H.C. Wainwright$7buy1535.51%UpsideReiterated08/24/26
William Blair―buy―Reiterated08/14/26
Needham$5buy1068.22%UpsideReiterated08/14/26
RBC Capital$5buy1068.22%UpsideReiterated08/14/26
J.P. Morgan―sell―Reiterated05/26/26
Guggenheim$14buy3171.03%UpsideReiterated05/07/26
Leerink Partners$8buy1769.16%UpsideInitiated01/11/26
Stocks with the Highest Top Analyst Consensus in the Healthcare Sector
MDWDMediwound
OVIDOvid Therapeutics
IMUXImmunic
QUITAchieve Life Sciences
COGTCogent Biosciences

Find stocks in the Healthcare sector that are highly recommended by Top Performing Analysts.

Best Analysts Covering Neumora Therapeutics, Inc.

3 Months
Brian Abrahams
Brian AbrahamsRBC Capital
Success Rate6/14 ratings generated profit
43%
Average Return
-16.06%

Copying Brian Abrahams's trades and holding each position for 3 Months would result in 42.86% of your transactions generating a profit, with an average return of -16.06% per trade.

1 Year
Graig Suvannavejh
Graig SuvannavejhMizuho Securities
Success Rate5/19 ratings generated profit
26%
Average Return
-33.93%

Copying Graig Suvannavejh's trades and holding each position for 1 Year would result in 26.32% of your transactions generating a profit, with an average return of -33.93% per trade.

2 Years
Graig Suvannavejh
Graig SuvannavejhMizuho Securities
Success Rate1/19 ratings generated profit
5%
Average Return
-71.85%

Copying Graig Suvannavejh's trades and holding each position for 2 Years would result in 5.26% of your transactions generating a profit, with an average return of -71.85% per trade.

NMRA Analyst Recommendation Trends

05101520Dec 25Jan 26Feb 26Mar 26Apr 26May 26Jun 26Jul 26Aug 26Sep 26Oct 26Nov 26
Monthly rating counts for NMRA
RatingJul 26Aug 26Sep 26Oct 26Nov 26
Strong Buy1514861
Buy33210
Hold10001
Sell10000
Strong Sell00000
total20171072

In the current month, NMRA has received 1 Buy Ratings, 1 Hold Ratings, and 0 Sell Ratings. NMRA average Analyst price target in the past 3 months is 5.00.

NMRA Financial Forecast

$-1$-0.5$0$0.5$1Q4 2025Q2 2026Q4 2026
Consensus$0.00

NMRA Sales Forecast

Next quarter’s sales forecast for NMRA is $0 with a range of ― to ―. The previous quarter’s sales results were $0. Its overall industry beat sales estimates 50.04% of the time in the past 12 months.

NMRA Stock Forecast FAQ

What is NMRA’s average 12-month price target, according to analysts?
Based on analyst ratings, Neumora Therapeutics, Inc.’s 12-month average price target is $5.00.
What is NMRA’s upside potential, based on the analysts’ average price target?
Neumora Therapeutics, Inc. has 1068.22% upside potential, based on the analysts’ average price target.
Can I see which stocks the top-ranking analysts are rating?
Yes, go to the Analysts’ Top Stocks tool to see stocks with a Strong Buy or Strong Sell analyst rating consensus, according to the top performers.
How can I follow the stock ratings of top Wall Street analysts?
Head over to our Expert Center to see a list of the top 100 Wall Street analysts and follow the analysts of your choice. Visit their profiles for more details about their stock ratings and see how they perform on a stock-by-stock basis.
Is NMRA a Buy, Sell or Hold?
Neumora Therapeutics, Inc. has a consensus rating of Moderate Buy which is based on 2 buy ratings, 0 hold ratings and 0 sell ratings.
What is Neumora Therapeutics, Inc.’s price target?
The average price target for Neumora Therapeutics, Inc. is $5.00. This is based on 2 12-month price targets, issued in the past 3 months. The highest analyst price target is $7.00, the lowest forecast is $3.00. The average price target represents a 1068.22% increase from the current price of $0.428.
What do analysts say about Neumora Therapeutics, Inc.?
Neumora Therapeutics, Inc.’s analyst rating consensus is a Moderate Buy. This is based on the ratings of 2 Wall Street analysts.
How can I buy shares of NMRA?
Open a brokerage account, see exclusive account opening deals on our Best Online Brokers page.